Browsing by Author CHAN WING YUEN,ELI

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 38 to 57 of 91 < previous   next >
Issue DateTitleAuthor(s)
2005Herb-drug interactions: A literature reviewHu, Z.; Yang, X.; Ho, P.C.L. ; Sui, Y.C. ; Heng, P.W.S. ; Chan, E. ; Duan, W.; Hwee, L.K. ; Zhou, S. 
2005Immune responses to water-soluble Ling Zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) P. Karst. Polysaccharides in patients with advanced colorectal cancerGao, Y.; Tang, W.; Dai, X.; Gao, H.; Chen, G.; Ye, J.; Chan, E. ; Huang, M.; Zhou, S. 
May-2004Immunomodulating activities of Ganoderma, a mushroom with medicinal propertiesGao, Y.; Chan, E. ; Zhou, S. 
Aug-2006Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in ratsZhao, L.-Z.; Huang, M.; Chen, J.; Ee, P.L.R. ; Chan, E. ; Duan, W.; Guan, Y.-Y.; Hong, Y.-H. ; Chen, X.; Zhou, S. 
2009Insights into the structure, function, and regulation of human cytochrome P450 1A2Zhou, S.-F.; Yang, L.-P.; Wei, M.Q.; Duan, W.; Chan, E. 
Sep-2009Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2Zhou, S.-F.; Yang, L.-P.; Zhou, Z.-W.; Liu, Y.-H.; Chan, E. 
Dec-2007Is a standard fixed dose of mycophenolate mofetil ideal for all patients?Yau, W.-P. ; Vathsala, A.; Lou, H.-X.; Chan, E. 
Jun-1997Lithium pharmacokinetics in Chinese manic-depressive patientsWing, Y.-K.; Chan, E. ; Chan, K.; Lee, S.; Shek, C.C.
Feb-2012Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley ratsSun, F. ; Li, J.; Yu, Q.; Chan, E. 
Jun-2009Mechanism-based enterohepatic circulation model of mycophenolic acid and its glucuronide metabolite: Assessment of impact of cyclosporine dose in asian renal transplant patientsYau, W.-P. ; Vathsala, A.; Lou, H.-X.; Zhou, S.; Chan, E. 
2005Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugsZhou, S. ; Chan, S.Y. ; Goh, B.C.; Chan, E. ; Duan, W.; Huang, M.; McLeod, H.L.
Jan-2005Multidrug resistance proteins (MRPs) and implication in drug developmentTian, Q. ; Zhang, J.; Chan, E. ; Duan, W.; Zhou, S. 
2005Novel agents that potentially inhibit irinotecan-induced diarrheaYang, X.; Hu, Z.; Chan, S.Y. ; Chan, E. ; Goh, B.C.; Duan, W.; Zhou, S. 
May-2006Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomideYang, X.-X.; Hu, Z.-P.; Chan, S.Y. ; Duan, W.; Ho, P.C.-L. ; Boelsterli, U.A.; Ng, K.-Y. ; Chan, E. ; Bian, J.-S.; Chen, Y.-Z. ; Huang, M.; Zhou, S.-F. 
Aug-2006Pharmacokinetics of recombinant human endostatin in ratsYang, X.-X.; Hu, Z.-P.; Chan, E. ; Duan, W.; Zhou, S. 
2001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S.; Hue, S.S.
2001Population pharmacokinetics of carbamazepine in Singapore epileptic patientsChan, E. ; Lee, H.S. ; Hue, S.S.
Aug-1990Population pharmacokinetics of phenytoin in Singapore ChineseChan, E. ; Ti, T.Y.; Lee, H.S.
2004Predicting pharmacokinetic herb-drug interactionsZhou, S. ; Chan, E. ; Li, S.C. ; Huang, M.; Chen, X.; Li, X.; Zhang, Q.; Paxton, J.W.
Sep-2009Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genesDi, Y.M.; Chan, E. ; Wei, M.Q.; Liu, J.-P.; Zhou, S.-F.